News and Publications

NEWS

04/04/2023

Arkuda Therapeutics Strengthens Management Team to Support Ongoing Discovery and Translation to the Clinic

Duane Burnett, PhD, appointed Chief Technology Officer, Raymond Hurst, PhD, promoted to Senior Vice President, Head o…

02/09/2022

Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases

Funding to support progression of lead progranulin enhancer program into IND-enabling studies Small molecule platform…

12/06/2021

Arkuda Therapeutics Awarded Michael J. Fox Foundation Grant to Accelerate Development of Compounds for Parkinson’s Disease

Watertown, MA – December 6, 2021 – Arkuda Therapeutics, a biotechnology company applying new insights at the inte…

PUBLICATIONS

10/07/2021

DISCOVERY OF SMALL MOLECULES FOR THE TREATMENT OF PD-GBA

Natasha Khatri, Mary K. Wozniak, Jerusha K. Brendel, Anna-Maria Alves, Christopher J. Holler, James C. Lanter, Duane …

04/08/2020

DISCOVERY OF NOVEL SMALL MOLECULES FOR THE TREATMENT OF FTD-GRN

Christopher J. Holler, Angela Chen, Natasha Khatri, James C. Lanter, Ricardo L. Sanz, Jerusha K. Brendel, Mary Woznia…